Company Overview and News

40
The Rout In Netflix Stock Is a Gift for Bulls

2018-07-17 investorplace
Recently, the stock market has been on a roller coaster ride from the slew of global tariff headlines most notable against China. So far, Netflix (NASDAQ:NFLX) has been somewhat sheltered from it since China is not the heart of the growth thesis. Consequently, NFLX stock just recently set a record high and had been up 100% year-to-date. But that all changed last night when Reed Hastings & Co. reported earnings after hours and investors hated it.
83GK FB AMZN GOOGL 84GK NFLX NYTAB

2
WYNN Stock: The Recent Fall in Wynn Resorts Stock Is an Opportunity for Bulls | InvestorPlace

2018-07-10 investorplace
The stock market has been in whipsaw mode since the correction started in February. First we had traders reacting to a hotter-than-expected wage inflation report. But then the headline mode switched completely to rhetoric from the White House about trade wars with China and Europe.
83GK WYNN 84GK

51
TSLA Stock: Go Long Tesla Stock On Today’s Dip! | InvestorPlace

2018-07-06 investorplace
Recently the stock market has been in turmoil due to the threats of global tariffs. Today we actually had the first wave of them imposed on $34 billion worth of Chinese imports into the U.S.
83GK 84GK TSLA

210
Go Long Netflix Stock Despite Trade War Uncertainty

2018-06-28 investorplace
This week has been volatile for stock prices. The White House escalated its rhetoric against China by threatening to limit Chinese Investments in the U.S. This is in addition to the already worrisome global tariff wars.
83GK FB 84GK AAPL NFLX DIS

113
Is Red Hat Stock a Falling Machete That’s Actually Worth Catching?

2018-06-22 investorplace
Red Hat (NYSE:RHT) reported earnings last night and Wall Street absolutely hated what they saw and heard. The options markets were only expecting a +/-$8, yet the stock is falling $23-per-share on the headline.
83GK MU 84GK RHT CRM

471
Catch the Applied Optoelectronics Inc Falling Knife With Confidence. | InvestorPlace

2018-06-11 investorplace
Applied Optoelectronics Inc (NASDAQ:AAOI) is falling 6% on a negative write-up from Rosenblatt Securities where they post a “sell” rating and lower price target to $30 per share. Luckily, the stock came into this morning up 20% year-to-date. So a small dip won’t kill the momentum.
83GK MU 84GK AAOI

0
Resverlogix 強調具備潛有將 Apabetalone 發展為一種通過“激活並殺死”方法根除 HIV-1 的治療藥物

2018-06-08 globenewswire
艾伯塔卡爾加里和波士頓, June 08, 2018 (GLOBE NEWSWIRE) -- 基於最近有關Apabetalone 在根除人類免疫缺陷病毒(HIV-1) 方面潛在作用的調查發現,Resverlogix Corp.(下稱“Resverlogix”或“公司”)(TSX:RVX) 正尋求與現有相關方合作共同抗擊HIV-1。 《自然》(Nature)的《中國藥理學報》(Acta Pharmacologica Sinica)(2018) 0:1–13 中一篇名為《BET 布羅莫結構域抑製劑Apabetalone 通過病毒激活誘使潛伏HIV-1 儲主細胞的細胞凋亡》(“The BET bromodomain inhibitor apabetalone induces apoptosis of latent HIV-1 reservoir cells following viral reactivation”)的文章顯示,Apabetalone 能夠揭露和激活潛伏HIV-1 儲主、誘使HIV-1 潛伏細胞死亡,並降低標準療法(cART 抗逆轉錄病毒聯合療法)的副作用。
83GK 84GK RVXCF RVX

0
Resverlogix 强调具备潜力将 Apabetalone 发展为一种通过“激活并杀死”的方法根除 HIV-1 的治疗药物

2018-06-08 globenewswire
艾伯塔卡尔加里和波士顿, June 08, 2018 (GLOBE NEWSWIRE) -- 基于最近有关Apabetalone 在根除人类免疫缺陷病毒(HIV-1) 方面潜在作用的调查发现,Resverlogix Corp.(下称“Resverlogix”或“公司”)(TSX:RVX) 正寻求与现有相关方合作共同抗击HIV-1。 《自然》(Nature)的《中国药理学报》(Acta Pharmacologica Sinica)(2018) 0:1–13 中一篇名为《BET 布罗莫结构域抑制剂Apabetalone 通过病毒激活诱使潜伏HIV-1 储主细胞的细胞凋亡》(“The BET bromodomain inhibitor apabetalone induces apoptosis of latent HIV-1 reservoir cells following viral reactivation”)的文章显示,Apabetalone 能够揭露和激活潜伏HIV-1 储主、诱使HIV-1 潜伏细胞死亡,并降低标准疗法(cART 抗逆转录病毒联合疗法)的副作用。
83GK 84GK RVXCF RVX

160
This Yelp Inc Stock Trade Will Fetch Positive Reviews | InvestorPlace

2018-06-07 investorplace
Yelp Inc (NYSE:YELP) stock fell 5% yesterday at a time when the stock markets in general were making new all-time highs. We had high-flying companies breaking stock price records, so it’s disappointing when the one stock falls on such a bullish day.
83GK YELP 84GK AAPL

0
Resverlogix Highlights Potential to Develop Apabetalone as a Therapeutic for HIV-1 Eradication Utilizing the “Shock and Kill” Approach

2018-06-07 globenewswire
CALGARY, Alberta and BOSTON, June 07, 2018 (GLOBE NEWSWIRE) -- Based on recent findings on apabetalone’s potential role in human immunodeficiency virus (“HIV-1”) eradication, Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is seeking a partnership with an existing stakeholder in the ongoing fight against HIV-1. The most recent publication titled: “The BET bromodomain inhibitor apabetalone induces apoptosis of latent HIV-1 reservoir cells following viral reactivation,” in Nature’s Acta Pharmacologica Sinica (2018) 0:1–13; demonstrated apabetalone’s abilities to expose and reactivate latent HIV-1 reservoirs, induce HIV-1 latent cell death, and reduce the side effects of standard of care (cART combination antiretroviral therapy).
83GK 84GK RVXCF RVX

199
TSLA Stock: Profit From Wall Street’s Recent Crush of Tesla Inc Stock | InvestorPlace

2018-06-06 investorplace
Tesla Inc (NASDAQ:TSLA) is a contentious stock to say the least. Emotions run high in the name, and it definitely is a momentum stock. Those are usually hard to trade. When they fall, they look like they are headed into an abyss. You may try to catch the proverbial knife, only to find out it’s a machete that cost investors’ digits.
83GK 84GK AAPL TSLA

6
PANW Stock: Fears in Palo Alto Networks Inc Stock Are Overblown -- Go Long | InvestorPlace

2018-06-05 investorplace
We now live in a world that depends on technology more than ever. And the adoption of the cloud has been increasing at an exponential rate, so this is a trend that won’t quit any time soon. With that comes the need for cyber security. Palo Alto Networks Inc (NYSE:PANW) is an early entrant into the field, so it has the setup to prosper for years to come.
83GK 84GK PANW

114
Box, Inc. Is Tanking — Catch It While You Can

2018-05-31 investorplace
Box, Inc. (NYSE:BOX) reported earnings last night and Wall Street did not like what it saw. The knee-jerk reaction was to sell BOX stock down 6% on the headline. It’s now off the lows but, clearly, investors are displeased.
83GK DBX AMZN GOOGL 84GK BOX GOOG

120
Gap Inc Stock Is In the Middle of a Red Tag Sale

2018-05-27 investorplace
Let me start by saying that I am not a fan of brick-and-mortar retail stocks. I don’t believe that they have solved the Amazon.com, Inc. (NASDAQ:AMZN) riddle yet. Yes, they’ve made strides towards stemming the bleeding, but the wounds are still open. So today’s trade is just that: A trade inside a conservative portfolio, not a long term investment.
83GK TGT AMZN 84GK M GPS

164
Shopify Inc Takes a Hit on Adobe Headline — Add It to Your Cart

2018-05-22 investorplace
Shopify Inc (NYSE:SHOP) stock is falling this morning on headlines that have little to do with its own operating conditions. Nevertheless, the stock has been on fire keeping up pace with the likes of Amazon.com Inc. (NASDAQ:AMZN). Even after this dip, SHOP is still up 30% year-to-date so the trajectory is likely to remain intact for now.
83GK SHOP AMZN 84GK ADBE

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...